Pharmaceutical bosses and the government are racing to stop Donald Trump from slapping tariffs on medicines in a move that would significantly impact Britain’s multibillion-pound industry.
The US president has warned he will impose a 25 per cent levy on foreign drugs, which would devastate UK giants GlaxoSmithKline and AstraZeneca.